SK

Sushmita Kumari

Active Director Director DIN 10192743
DIN 10192743 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushmita Kumari

Data last updated:

Sushmita Kumari is a Director at Aled Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10192743
Primary Designation Director
Industry Pharma
First Appointment 06 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aled Pharmaceuticals Private Limited U46909BR2023PTC063545
Director06 Jun 20232023Active

Board colleagues of Sushmita Kumari

Directorship timeline

Open interactive timeline →
Aled Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushmita Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushmita Kumari

Sushmita Kumari currently holds 1 directorship: Aled Pharmaceuticals Private Limited (Director, since 06 Jun 2023).

Sushmita Kumari was first appointed on 06 Jun 2023 as Director at Aled Pharmaceuticals Private Limited.

The current boards of Sushmita Kumari's companies include Rakesh Kumar (Aled Pharmaceuticals Private Limited), Sudhir Kumar (Aled Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available